Novo Nordisk (NYSE: NVO) Stock Price Gains Ground As UK Approves Wegovy Pill For Weight Management

Novo Nordisk (NYSE: NVO) Stock Price Gains Ground As UK Approves Wegovy Pill For Weight Management

Novo Nordisk A/S (NYSE: NVO) is drawing renewed investor attention as analysts identify the Danish pharmaceutical giant as one of the best low volatility stocks trading under $50. The company secured a landmark regulatory win on June 11, when the United Kingdom’s Medicines and Healthcare products Regulatory Agency approved the Wegovy pill for weight management. The approval makes the Wegovy pill the first oral glucagon-like peptide-1 receptor ag…